09:00-09:30 Registration
09:30-09:33 Presidential opening Christianne Lok
09:33-09:40 Welcome address Rector of MUW
prof. Zbigniew Gaciong
09:40-10:50 Session 1. Diagnostics | Chairs: Lone Sunde & Michal Pyzlak
09:40-10:00 An evolution of pathologic changes from PSN to PSTT Jolanta Kupryjanczyk & Michal Pyzlak (Poland)
10:00-10:10 Liquid biopsy in the diagnostics Lone Sunde (Denmark)
10:10-10:20 The resolving of inconsistent p57 staining Fabienne Allias-Montmayeur (France)
10:20-10:40 Central pathology review Baljeet Kaur (United Kingdom)
10:40-10:50 Discussion
10:50-11:55 Session 2. Low-risk | Chairs: Leon Massuger & Grzegorz Szewczyk
10:50-10:57 Case report of a low-risk patient Paulina Dąbrowska (Poland)
10:57-11:10 Refining the FIGO score Yalck Eysbouts
(The Netherlands)
11:10-11:25 Hydatidiform mole with a coexisting live fetus – diagnosis and management Leonor Coopmans
(The Netherlands)
11:25-11:45 First line treatment: pro 8-day MTX/FA regimen: or pro Act-D. Matthew Winter
(United Kingdom)
11:45-11:55 Discussion
11:55-12:30 Coffee break
12:30-13:30 Session 3. hCG aspects | Chairs: Fred Sweep & Matthew Winter
12:30-12:40 Quality over quantity – external quality assessment for the measurement of hCG Nick Unsworth
(United Kingdom)
12:40-12:50 Predicting a response on the base of hCG measurements Fred Sweep (The Netherlands)
12:50-13:00 Challenges in hCG measurement Caroline Joyce (Ireland)
13:00-13:10 Modern solutions in hCG measurements Roche diagnostics
(sponsored lecture)
13:10-13:20 EOTTD hCG questionnaire L. McMahon
(United Kingdom)
13:20-13:30 Discussion
13:30-14:30 Lunch break
14:30-15:30 Session 4. GTD Centers | Chair: Christianne Lok
14:30-14:40 The building of a GTD team – role of nurses Caitriona Kennely (Ireland)
14:40-14:50 Post chemo care online support groups – the Sheffield experience Kam Singh (United Kingdom)
14:50-14:57 Single centre experience Erika Utracka (Czech Republic)
14:57-15:04 Single centre experience Luisa Skupin (Germany)
15:04-15:11 Single centre experience Frederic Goffin (Belgium)
15:11-15:25 Registration of GTD cases – obligatory: Nienke van Trommel (The Netherlands), voluntary: G. Marquina
15:25-15:30 Discussion
15:30-16:00 Coffee break
16:00-17:00 Session 5. High-Risk GTN | Chair: John Coulter
16:00-16:07 Case report of a high-risk patient Małgorzata Kuc-Rajca (Poland)
16:07-16:20 Treatment of relapse and recurrent disease John Coulter (Ireland)
16:20-16:30 Practical issues of immunotherapy in GTD Ehsan Ghorani (United Kingdom)
16:30-16:45 Immunotherapy after MTX – Jérôme Massardier (France) or after EMA/CO – Michael Seckl (United Kingdom)
16:45-17:45 Discussion
17:45-17:50 First-day closure – Grzegorz Szewczyk
09:00-11:00 Working parties


clinical: room 231/232

hCG: room 233

pathology/genetics: room 234 

nurses: room 142


11:00-11:30 Coffee break
11:30-12:30 Working parties report Aula B
12:30-13:15 EOTTD general assembly Aula B
13:15-13:20 Closing remarks Aula B